[Modulating endoplasmic reticulum stress in the treatment of cancer]

Med Sci (Paris). 2015 Jun-Jul;31(6-7):667-73. doi: 10.1051/medsci/20153106021. Epub 2015 Jul 7.
[Article in French]

Abstract

An imbalance of protein homeostasis caused by external or internal stress in the endoplasmic reticulum triggers the initiation of signalling pathways downstream of the IRE1, ATF6 and PERK sensors to a translational or transcriptional adaptive response known as UPR (Unfolded Protein Response). According to the intensity and duration of stress, the dual function of the UPR leads to either cell adaptation or cell death. UPR pathways in cancer cells are often altered and generally lead to an adaptation to an hostile environment. As the UPR becomes an emerging therapeutic target due to its increasing contribution to various diseases, we describe in this review various strategies that have been developed to discover new compounds enabling to manipulate the magnitude of ER stress in the context of cancer.

Publication types

  • Review

MeSH terms

  • Animals
  • Antineoplastic Agents / therapeutic use*
  • Endoplasmic Reticulum Stress / drug effects*
  • Endoribonucleases / antagonists & inhibitors
  • Endoribonucleases / metabolism
  • Humans
  • Molecular Targeted Therapy / methods*
  • Neoplasms / drug therapy*
  • Neoplasms / metabolism
  • Protein Serine-Threonine Kinases / antagonists & inhibitors
  • Protein Serine-Threonine Kinases / metabolism
  • Signal Transduction / drug effects
  • Unfolded Protein Response / drug effects
  • eIF-2 Kinase / antagonists & inhibitors
  • eIF-2 Kinase / metabolism

Substances

  • Antineoplastic Agents
  • EIF2AK3 protein, human
  • ERN1 protein, human
  • Protein Serine-Threonine Kinases
  • eIF-2 Kinase
  • Endoribonucleases